Brussels will buy an additional batch of Remdesivir – enough to treat thousands of Covid-19 patients – from US pharma company Gilead after countries across Europe reported shortages of the crucial anti-viral drug.
Gilead will ship nearly 20,300 additional doses to the EU for the treatment of around 3,400 patients under a new deal inked with the European Commission. The new supply, which is in addition to the 30,000 doses already bought in July, will cost €7 million ($8.2 million).
Continue reading https://on.rt.com/aryv